00
Days
00
Hrs
00
Min
00
Sec
Submit Your Paper

Generative AI in Healthcare: Transforming Medical Imaging, Accelerating Drug Discovery, and Enhancing Clinical Decision-Making

Authors

Mohit Sharma

Allied Health Sciences Department, Chitkara School of Health Sciences, Chitkara University, Punjab India-140401 (IN)

Khursheed Ahmad Ganie

Allied Health Sciences Department, Chitkara School of Health Sciences, Chitkara University, Punjab India-140401 (IN)

Priti Panwar

Allied Health Sciences Department, Chitkara School of Health Sciences, Chitkara University, Punjab India-140401 (IN)

Arti

Department of Life Sciences Rayat Bahra University, Punjab-140103 (IN)

Article Information

DOI: 10.51583/IJLTEMAS.2025.1412000008

Subject Category: Generative AI in Healthcare

Volume/Issue: 14/12 | Page No: 61-78

Publication Timeline

Submitted: 2025-12-26

Published: 2025-12-26

Abstract

Generative Artificial Intelligence (AI) is revolutionizing healthcare with its transformative potential in medical imaging, drug discovery, and clinical decision-making. Generative models such as Generative Adversarial Networks (GANs), Variational Autoencoders (VAEs), and large foundation models can synthesize realistic data, emulate biological systems, and accelerate innovation beyond traditional AI methods. In medical imaging, generative AI enhances diagnostic accuracy by enabling high-resolution image reconstruction, noise reduction, anatomical segmentation, and the creation of synthetic datasets to support algorithm training in data-scarce environments. These advancements assist radiologists in early disease detection, treatment planning, and longitudinal patient monitoring. In drug discovery, generative AI accelerates molecule design, lead optimization, and prediction of protein-ligand interactions, reducing time and cost while enabling precision therapeutics and drug repurposing. Clinically, it supports automated report generation, patient-specific treatment simulations, and digital twin development for disease modeling and trial optimization through synthetic patient cohorts. Despite these advances, challenges persist regarding data quality, interpretability, regulatory approval, ethical transparency, and bias mitigation, which are critical for ensuring patient trust and safety. This study explores generative AI’s applications across medical imaging, pharmacology, and clinical workflows, highlighting its opportunities, limitations, and future directions toward sustainable, ethical, and patient-centered healthcare integration.

Keywords

Generative AI, Medical Imaging, Drug Discovery, Clinical Applications, Synthetic Data etc

Downloads

References

1. Cacciamani GE, Siemens DR, Gill I. Generative artificial intelligence in health care. J Urol. 2023;210(5):723–5. [Google Scholar] [Crossref]

2. Kingma DP, Welling M. Auto-encoding variational bayes. arXiv preprint arXiv:1312.6114. 2013 Dec 20. [Google Scholar] [Crossref]

3. Goodfellow IJ, Pouget-Abadie J, Mirza M, et al. Generative adversarial nets. Adv Neural Inf Process Syst. 2014;27. [Google Scholar] [Crossref]

4. Rombach R, Blattmann A, Lorenz D, et al. High-resolution image synthesis with latent diffusion models. In: Proc IEEE/CVF Conf Comput Vis Pattern Recognit; 2022. p. 10684–95. [Google Scholar] [Crossref]

5. Ho J, Jain A, Abbeel P. Denoising diffusion probabilistic models. Adv Neural Inf Process Syst. 2020;33:6840–51. [Google Scholar] [Crossref]

6. Vaswani A, Shazeer N, Parmar N, et al. Attention is all you need. Adv Neural Inf Process Syst. 2017;30. [Google Scholar] [Crossref]

7. Singhal K, Azizi S, Tu T, et al. Large language models encode clinical knowledge. Nature. 2023;620(7972):172–80. [Google Scholar] [Crossref]

8. Chen RJ, Lu MY, Chen TY, et al. Synthetic data in machine learning for medicine and healthcare. Nat Biomed Eng. 2021;5(6):493–7. [Google Scholar] [Crossref]

9. Armanious K, Jiang C, Fischer M, et al. MedGAN: Medical image translation using GANs. Comput Med Imaging Graph. 2020;79:101684. [Google Scholar] [Crossref]

10. Zhavoronkov A, Ivanenkov YA, Aliper A, et al. Deep learning enables rapid identification of potent DDR1 kinase inhibitors. Nat Biotechnol. 2019;37(9):1038–40. [Google Scholar] [Crossref]

11. Sanchez-Lengeling B, Aspuru-Guzik A. Inverse molecular design using machine learning: generative models for matter engineering. Science. 2018;361(6400):360–5. [Google Scholar] [Crossref]

12. Patel BN, Rosenberg L, Willcox G, et al. Human–machine partnership with artificial intelligence for chest radiograph diagnosis. NPJ Digit Med. 2019;2(1):111. [Google Scholar] [Crossref]

13. Esteva A, Chou K, Yeung S, et al. Deep learning-enabled medical computer vision. NPJ Digit Med. 2021;4(1):5. [Google Scholar] [Crossref]

14. Mittelstadt BD, Allo P, Taddeo M, et al. The ethics of algorithms: mapping the debate. Big Data Soc. 2016;3(2):2053951716679679. [Google Scholar] [Crossref]

15. Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25(1):44–56. [Google Scholar] [Crossref]

16. Yi X, Walia E, Babyn P. Generative adversarial network in medical imaging: a review. Med Image Anal. 2019;58:101552. [Google Scholar] [Crossref]

17. Dhariwal P, Nichol A. Diffusion models beat GANs on image synthesis. Adv Neural Inf Process Syst. 2021;34:8780–94. [Google Scholar] [Crossref]

18. Chung H, Lee ES, Ye JC. MR image denoising and super-resolution using regularized reverse diffusion. IEEE Trans Med Imaging. 2022;42(4):922–34. [Google Scholar] [Crossref]

19. Bond-Taylor S, Leach A, Long Y, et al. Deep generative modelling: a comparative review of VAEs, GANs, normalizing flows, energy-based and autoregressive models. IEEE Trans Pattern Anal Mach Intell. 2021;44(11):7327–47. [Google Scholar] [Crossref]

20. Zimmerer D, Kohl SA, Petersen J, et al. Context-encoding variational autoencoder for unsupervised anomaly detection. arXiv preprint arXiv:1812.05941. 2018 Dec 14. [Google Scholar] [Crossref]

21. Burgess CP, Higgins I, Pal A, et al. Understanding disentangling in β-VAE. arXiv preprint arXiv:1804.03599. 2018 Apr 10. [Google Scholar] [Crossref]

22. Wolterink JM, Leiner T, Viergever MA, et al. Generative adversarial networks for noise reduction in low-dose CT. IEEE Trans Med Imaging. 2017;36(12):2536–45. [Google Scholar] [Crossref]

23. Salimans T, Goodfellow I, Zaremba W, et al. Improved techniques for training GANs. Adv Neural Inf Process Syst. 2016;29. [Google Scholar] [Crossref]

24. Chen S. A review of multimodal large model-based medical image report generation. Front Med Sci Res. 2025;7(3). [Google Scholar] [Crossref]

25. Lundervold AS, Lundervold A. An overview of deep learning in medical imaging focusing on MRI. Z Med Phys. 2019;29(2):102–27. [Google Scholar] [Crossref]

26. Frid-Adar M, Klang E, Amitai M, et al. Synthetic data augmentation using GAN for improved liver lesion classification. In: IEEE Int Symp Biomed Imaging; 2018. p. 289–93. [Google Scholar] [Crossref]

27. Han C, Rundo L, Araki R, et al. Infinite brain MR images: PGGAN-based data augmentation for tumor detection. In: Neural Approaches to Dynamics of Signal Exchanges. Singapore: Springer; 2019. p. 291–303. [Google Scholar] [Crossref]

28. Shin HC, Tenenholtz NA, Rogers JK, et al. Medical image synthesis for data augmentation and anonymization using GANs. In: Simulation and Synthesis in Medical Imaging. Cham: Springer; 2018. p. 1–11. [Google Scholar] [Crossref]

29. Chartsias A, Joyce T, Giuffrida MV, et al. Multimodal MR synthesis via modality-invariant latent representation. IEEE Trans Med Imaging. 2017;37(3):803–14. [Google Scholar] [Crossref]

30. Wolterink JM, Dinkla AM, Savenije MH, et al. Deep MR to CT synthesis using unpaired data. In: Simulation and Synthesis in Medical Imaging. Cham: Springer; 2017. p. 14–23. [Google Scholar] [Crossref]

31. Hiasa Y, Otake Y, Takao M, et al. Cross-modality image synthesis from unpaired data using CycleGAN. In: Simulation and Synthesis in Medical Imaging. Cham: Springer; 2018. p. 31–41. [Google Scholar] [Crossref]

32. Hammernik K, Klatzer T, Kobler E, et al. Learning a variational network for reconstruction of accelerated MRI data. Magn Reson Med. 2018;79(6):3055–71. [Google Scholar] [Crossref]

33. Xue Y, Xu T, Zhang H, et al. SEGAN: Adversarial network with multi-scale L1 loss for medical image segmentation. Neuroinformatics. 2018;16(3):383–92. [Google Scholar] [Crossref]

34. Zhang Z, Yao L, Wang B, et al. Diffboost: Enhancing medical image segmentation via text-guided diffusion model. IEEE Trans Med Imaging. 2024;17 Dec. [Google Scholar] [Crossref]

35. Dewey BE, Zhao C, Reinhold JC, et al. DeepHarmony: A deep learning approach to contrast harmonization across scanner changes. Magn Reson Imaging. 2019;64:160–70. [Google Scholar] [Crossref]

36. Pinto MS, Paolella R, Billiet T, et al. Harmonization of brain diffusion MRI: concepts and methods. Front Neurosci. 2020;14:396. [Google Scholar] [Crossref]

37. Cohen JP, Luck M, Honari S. Distribution matching losses can hallucinate features in medical image translation. In: MICCAI Conf Med Image Comput Comput-Assist Interv. Cham: Springer; 2018. p. 529–36. [Google Scholar] [Crossref]

38. D’Antonoli TA. Ethical considerations for artificial intelligence: an overview of the current radiology landscape. Diagn Interv Radiol. 2020;26(5):504. [Google Scholar] [Crossref]

39. Gómez-Bombarelli R, Wei JN, Duvenaud D, et al. Automatic chemical design using a data-driven continuous representation of molecules. ACS Cent Sci. 2018;4(2):268–76. [Google Scholar] [Crossref]

40. Simonovsky M, Komodakis N. GraphVAE: Towards generation of small graphs using variational autoencoders. In: Int Conf Artif Neural Netw. Cham: Springer; 2018. p. 412–22. [Google Scholar] [Crossref]

41. Hoogeboom E, Satorras VG, Vignac C, et al. Equivariant diffusion for molecule generation in 3D. In: Int Conf Mach Learn. 2022. p. 8867–87. [Google Scholar] [Crossref]

42. Segler MH, Kogej T, Tyrchan C, et al. Generating focused molecule libraries for drug discovery with recurrent neural networks. ACS Cent Sci. 2018;4(1):120–31. [Google Scholar] [Crossref]

43. Nigam A, Pollice R, Krenn M, et al. Beyond generative models: superfast traversal, optimization, novelty, exploration and discovery (STONED) algorithm for molecules using SELFIES. Chem Sci. 2021;12(20):7079–90. [Google Scholar] [Crossref]

44. Chen H, Engkvist O, Wang Y, et al. The rise of deep learning in drug discovery. Drug Discov Today. 2018;23(6):1241–50. [Google Scholar] [Crossref]

45. Popova M, Isayev O, Tropsha A. Deep reinforcement learning for de novo drug design. Sci Adv. 2018;4(7):eaap7885. [Google Scholar] [Crossref]

46. Gao W, Coley CW. The synthesizability of molecules proposed by generative models. J Chem Inf Model. 2020;60(12):5714–23. [Google Scholar] [Crossref]

47. Jumper J, Evans R, Pritzel A, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583–9. [Google Scholar] [Crossref]

48. Strokach A, Becerra D, Corbi-Verge C, et al. Fast and flexible design of novel proteins using graph neural networks. bioRxiv. 2019 Dec 10:868935. [Google Scholar] [Crossref]

49. Repecka D, Jauniskis V, Karpus L, et al. Expanding functional protein sequence spaces using generative adversarial networks. Nat Mach Intell. 2021;3(4):324–33. [Google Scholar] [Crossref]

50. Anishchenko I, Pellock SJ, Chidyausiku TM, et al. De novo protein design by deep network hallucination. Nature. 2021;600(7889):547–52. [Google Scholar] [Crossref]

51. Coley CW, Green WH, Jensen KF. Machine learning in computer-aided synthesis planning. Acc Chem Res. 2018;51(5):1281–9. [Google Scholar] [Crossref]

52. Schwaller P, Vaucher AC, Laino T, et al. Prediction of chemical reaction yields using deep learning. Mach Learn Sci Technol. 2021;2(1):015016. [Google Scholar] [Crossref]

53. Elton DC, Boukouvalas Z, Fuge MD, et al. Deep learning for molecular design—a review of the state of the art. Mol Syst Des Eng. 2019;4(4):828–49. [Google Scholar] [Crossref]

54. Arús-Pous J, Blaschke T, Ulander S, et al. Exploring the GDB-13 chemical space using deep generative models. J Cheminform. 2019;11(1):20. [Google Scholar] [Crossref]

55. Griffiths RR, Hernández-Lobato JM. Constrained Bayesian optimization for automatic chemical design using variational autoencoders. Chem Sci. 2020;11(2):577–86. [Google Scholar] [Crossref]

56. Shanafelt TD, Dyrbye LN, Sinsky C, et al. Relationship between clerical burden and characteristics of the electronic environment with physician burnout. Mayo Clin Proc. 2016;91(7):836–48. [Google Scholar] [Crossref]

57. Teng F, Ma Z, Chen J, et al. Automatic medical code assignment via deep learning approach for intelligent healthcare. IEEE J Biomed Health Inform. 2020;24(9):2506–15. [Google Scholar] [Crossref]

58. Baker HP, Dwyer E, Kalidoss S, et al. ChatGPT's ability to assist with clinical documentation: a randomized controlled trial. JAAOS. 2024;32(3):123–9. [Google Scholar] [Crossref]

59. Agrawal A, Gans J, Goldfarb A. Power and Prediction: The Disruptive Economics of Artificial Intelligence. Cambridge, MA: Harvard Business Press; 2022. [Google Scholar] [Crossref]

60. Obermeyer Z, Emanuel EJ. Predicting the future—big data, machine learning, and clinical medicine. N Engl J Med. 2016;375(13):1216. [Google Scholar] [Crossref]

61. Jin Q, Yuan Z, Xiong G, et al. Biomedical question answering: a survey of approaches and challenges. ACM Comput Surv. 2022;55(2):1–36. [Google Scholar] [Crossref]

62. Nori H, King N, McKinney SM, et al. Capabilities of GPT-4 on medical challenge problems. arXiv preprint arXiv:2303.13375. 2023 Mar 20. [Google Scholar] [Crossref]

63. Rajpurkar P, Chen E, Banerjee O, et al. AI in health and medicine. Nat Med. 2022;28(1):31–8. [Google Scholar] [Crossref]

64. Miotto R, Li L, Kidd BA, et al. Deep patient: an unsupervised representation to predict the future of patients from EHRs. Sci Rep. 2016;6(1):26094. [Google Scholar] [Crossref]

65. Wang Y, Yin C, Zhang P. Multimodal risk prediction with physiological signals, medical images and clinical notes. Heliyon. 2024;10(5). [Google Scholar] [Crossref]

66. Pinaya WH, Tudosiu PD, Dafflon J, et al. Brain imaging generation with latent diffusion models. In: MICCAI Workshop on Deep Generative Models. Cham: Springer; 2022. p. 117–26. [Google Scholar] [Crossref]

67. Holzinger A, Carrington A, Müller H. Measuring the quality of explanations: the system causability scale (SCS). KI-Künstl Intell. 2020;34(2):193–8. [Google Scholar] [Crossref]

68. Ji Z, Lee N, Frieske R, et al. Survey of hallucination in natural language generation. ACM Comput Surv. 2023;55(12):1–38. [Google Scholar] [Crossref]

69. Lewis P, Perez E, Piktus A, et al. Retrieval-augmented generation for knowledge-intensive NLP tasks. Adv Neural Inf Process Syst. 2020;33:9459–74. [Google Scholar] [Crossref]

70. Macrae C. Governing the safety of artificial intelligence in healthcare. BMJ Qual Saf. 2019;28(6):495–8. [Google Scholar] [Crossref]

71. Amann J, Blasimme A, Vayena E, et al. Explainability for artificial intelligence in healthcare: a multidisciplinary perspective. BMC Med Inform Decis Mak. 2020;20(1):310. [Google Scholar] [Crossref]

72. Varoquaux G, Cheplygina V. Machine learning for medical imaging: methodological failures and recommendations. NPJ Digit Med. 2022;5(1):48. [Google Scholar] [Crossref]

73. Preiksaitis C, Rose C. Opportunities and challenges of generative artificial intelligence in medical education: a scoping review. JMIR Med Educ. 2023;9:e48785. [Google Scholar] [Crossref]

74. Ibrahim H, Liu X, Rivera SC, et al. Reporting guidelines for clinical trials of artificial intelligence interventions: the SPIRIT-AI and CONSORT-AI guidelines. Trials. 2021;22(1):11. [Google Scholar] [Crossref]

75. Nagendran M, Chen Y, Lovejoy CA, et al. Artificial intelligence versus clinicians: systematic review of design and reporting standards. BMJ. 2020;368. [Google Scholar] [Crossref]

76. Kaladharan S, Manayath D, Gopalakrishnan R. Regulatory challenges in AI/ML-enabled medical devices: a scoping review. J Med Devices. 2024;18(4):040801. [Google Scholar] [Crossref]

77. Pannonhalmi Á, Sipos B, Kurucz RI, et al. Advancing regulatory oversight of medical device trials to align with clinical drug standards in the European Union. Pharmaceuticals. 2025;18(6):876. [Google Scholar] [Crossref]

78. Yale AJ. Privacy-preserving synthetic health data generation and evaluation. Rensselaer Polytechnic Institute; 2020. [Google Scholar] [Crossref]

79. Stadler T, Oprisanu B, Troncoso C. Synthetic data–anonymisation groundhog day. In: 31st USENIX Security Symposium (USENIX Security 22); 2022. p. 1451–68. [Google Scholar] [Crossref]

80. Obermeyer Z, Powers B, Vogeli C, et al. Dissecting racial bias in an algorithm used to manage population health. Science. 2019;366(6464):447–53. [Google Scholar] [Crossref]

81. Seyyed-Kalantari L, Zhang H, McDermott MB, et al. Underdiagnosis bias of AI algorithms in chest radiographs. Nat Med. 2021;27(12):2176–82. [Google Scholar] [Crossref]

82. Price WN, Gerke S, Cohen IG. Potential liability for physicians using artificial intelligence. JAMA. 2019;322(18):1765–6. [Google Scholar] [Crossref]

83. Mennella C, Maniscalco U, De Pietro G, et al. Ethical and regulatory challenges of AI technologies in healthcare: a narrative review. Heliyon. 2024;10(4). [Google Scholar] [Crossref]

84. Grote T, Berens P. On the ethics of algorithmic decision-making in healthcare. J Med Ethics. 2020;46(3):205–11. [Google Scholar] [Crossref]

85. Mittelstadt B. Principles alone cannot guarantee ethical AI. Nat Mach Intell. 2019;1(11):501–7. [Google Scholar] [Crossref]

Metrics

Views & Downloads

Similar Articles

© 2026 IJLTEMAS · RSIS International. All rights reserved. ISSN 2278-2540.